Form D — RedShift BioAnalytics, Inc.
0001349049-25-000002 · filed Jun 26, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Other Technology filings
Offering
- Industry
- Other Technology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $7,065,195
- Reported amount sold
- $5,914,304
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- RedShift BioAnalytics, Inc.
- CIK
- 1349049
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 80 Central Street
Boxborough, Massachusetts 01719 - Phone
- 781-345-7300
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Thomas O'Lenic · Executive OfficerBoxborough, Massachusetts Find on LinkedIn ↗
-
William Cadogan · DirectorBoxborough, Massachusetts Find on LinkedIn ↗
-
Frank Smith · DirectorBoxborough, Massachusetts Find on LinkedIn ↗
-
Bryson Hollimon · DirectorBoxborough, Massachusetts Find on LinkedIn ↗
-
Wouter Meuleman · DirectorBoxborough, Massachusetts Find on LinkedIn ↗
-
Susan Holleran · DirectorBoxborough, Massachusetts Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗